Phase 2 Aplastic Anaemia Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
Elderly (People Aged 65 or More)Sever Aplastic AnaemiaImmunosuppressive Treatment
Institute of Hematology & Blood Diseases Hospital, China65 enrolled1 locationNCT07010237
Recruiting
Phase 2
Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A
Aplastic Anaemia
Peking Union Medical College Hospital40 enrolled1 locationNCT06802055
Recruiting
Phase 2
REscuing bone marrow function in patients with aplaStic anaEmia and bone marrow faiLure post allogEneiC Transplantation (RESELECT) Phase I/II single arm with historical control study assessing the efficacy and safety of Atorvastatin and N-Acetyl Cysteine in the treatment of Poor Graft Function post allogeneic transplantation and relapsed/refractory aplastic anaemia
One of the health conditions being studied in this trial will be Poor Graft FunctionOne of the health conditions being studied in this trial will be Aplastic Anaemia
The Royal Melbourne Hospital20 enrolled1 locationACTRN12620001339943
Active
Phase 2
Avatrombopag in Relapsed or Refractory Severe Aplastic Anaemia – a Bayesian Optimal Phase II study
Refractory/relapsed severe aplastic anaemia
Monash University55 enrolled12 locationsACTRN12619001043123
Active
Phase 2
Avatrombopag in untreated severe aplastic anaemia - a Bayesian optimal phase 2 study
Newly diagnosed severe aplastic anaemia
Monash University55 enrolled12 locationsACTRN12619001042134